Net Worth Advisory Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
8,520
-365
-4% -$42.7K 0.28% 73
2026
Q1
$1.07M Sell
8,885
-202
-2% -$23.3K 0.22% 88
2025
Q4
$957K Buy
9,087
+3,507
+63% +$329K 0.19% 97
2025
Q3
$468K Sell
5,580
-933
-14% -$76.8K 0.14% 173
2025
Q2
$516K Sell
6,513
-8,491
-57% -$675K 0.11% 189
2025
Q1
$1.35M Buy
15,004
+1,441
+11% +$135K 0.42% 35
2024
Q4
$1.35M Sell
13,563
-1,384
-9% -$143K 0.41% 39
2024
Q3
$1.7M Buy
+14,947
New +$1.78M 0.5% 33

Other funds holding MRK

Net Worth Advisory Group's MRK Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Merck (MRK) stake by 4.1% in Q2 2026, selling an estimated $42.7K and leaving 8,520 shares worth $1.09M. The position accounts for 0.28% of the portfolio, ranked #73.

Net Worth Advisory Group first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.7M in Q3 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Net Worth Advisory Group held 8,520 shares of Merck worth $1.09M as of Q2 2026.
  • Net Worth Advisory Group sold 365 Merck shares in Q2 2026, an estimated $42.7K.
  • Merck made up 0.28% of Net Worth Advisory Group's portfolio in Q2 2026, its #73 holding.
  • Net Worth Advisory Group first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • Net Worth Advisory Group's Merck position peaked at $1.7M in Q3 2024.
  • 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.